Trial Profile
Phase 3 Clinical Trial with MD-0901
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Mochida Pharmaceutical
- 06 Jun 2016 New trial record